pGIPz-mPD-L1 Citations (4)

Originally described in: Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity.
Li CW, Lim SO, Xia W, Lee HH, Chan LC, Kuo CW, Khoo KH, Chang SS, Cha JH, Kim T, Hsu JL, Wu Y, Hsu JM, Yamaguchi H, Ding Q, Wang Y, Yao J, Lee CC, Wu HJ, Sahin AA, Allison JP, Yu D, Hortobagyi GN, Hung MC Nat Commun. 2016 Aug 30;7:12632. doi: 10.1038/ncomms12632. PubMed Journal

---

Articles Citing pGIPz-mPD-L1

Articles
Intronic Cis-Element DR8 in hTERT Is Bound by Splicing Factor SF3B4 and Regulates hTERT Splicing in Non-Small Cell Lung Cancer. Slusher AL, Kim JJ, Ribick M, Pollens-Voigt J, Bankhead A, Palmbos PL, Ludlow AT. Mol Cancer Res. 2022 Oct 4;20(10):1574-1588. doi: 10.1158/1541-7786.MCR-21-0058. PubMed
p53 Inhibits Bmi-1-driven Self-Renewal and Defines Salivary Gland Cancer Stemness. Rodriguez-Ramirez C, Zhang Z, Warner KA, Herzog AE, Mantesso A, Zhang Z, Yoon E, Wang S, Wicha MS, Nor JE. Clin Cancer Res. 2022 Nov 1;28(21):4757-4770. doi: 10.1158/1078-0432.CCR-22-1357. PubMed
High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNgamma Signaling Pathway Defects. Kawase K, Kawashima S, Nagasaki J, Inozume T, Tanji E, Kawazu M, Hanazawa T, Togashi Y. Cancer Immunol Res. 2023 Jul 5;11(7):895-908. doi: 10.1158/2326-6066.CIR-22-0815. PubMed
Normalization of Snai1-mediated vessel dysfunction increases drug response in cancer. Hoffmann H, Wartenberg M, Vorlova S, Karl-Scholler F, Kallius M, Reinhardt O, Ozturk A, Schuhmair LS, Burkhardt V, Gatzner S, Scheld D, Nandigama R, Zernecke A, Herterich S, Ergun S, Rosenwald A, Henke E. Oncogene. 2024 Aug;43(35):2661-2676. doi: 10.1038/s41388-024-03113-1. Epub 2024 Aug 2. PubMed

If you have published an article using this material, please email us at to have your article added to this page.